Related references
Note: Only part of the references are listed.EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update
Michael Glikson et al.
EUROPACE (2020)
Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism - First Results From the SALUTE Trial -
Kazutaka Aonuma et al.
CIRCULATION JOURNAL (2018)
5-Year Outcomes After Left Atrial Appendage Closure From the PREVAIL and PROTECT AF Trials
Vivek Y. Reddy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation
Vivian Wing-Yan Lee et al.
BMC CARDIOVASCULAR DISORDERS (2016)
Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy
David R. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Patient Preferences for Coronary Artery Bypass Graft Surgery or Percutaneous Intervention in Multivessel Coronary Artery Disease
Ryan Kipp et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2013)
Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: A single-center observational study
Miyoko Naganuma et al.
THROMBOSIS RESEARCH (2012)
Safety of Percutaneous Left Atrial Appendage Closure Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry
Vivek Y. Reddy et al.
CIRCULATION (2011)
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
David R. Holmes et al.
LANCET (2009)